Cite

    Numajiri, H. et al. (2018). Rapid alteration of serum interleukin‐6 levels may predict the reactivity of i.v. cyclophosphamide pulse therapy in systemic sclerosis‐associated interstitial lung disease. Journal of dermatology. 45 (10), pp. 1221-1224. [Online].